Israel has a robust and growing pharmaceutical industry, particularly for biopharmaceuticals and advanced therapeutic medicinal products (ATMP). It is home to one of the largest generic drug companies in the world, which invests in Israeli drug development companies supporting the growth and development of new medicines. Because of its close links with Europe and the US, many of the new products being developed in Israel undergo clinical trials in Europe and the USA.  Rachel Griffiths of Biotec Services International explores the legislation that has been passed to make the transfer of medicinal products between countries easier.